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The effectiveness of microencapsulation system for targeted delivery of probiotics 
depends on its ability to protect cells from harsh gastrointestinal conditions of 
stomach followed by effectively releasing the cells in intestinal conditions.  
Oppositely charged xanthan and chitosan form stable polyelectrolytic hydrogels 
capable of encapsulating enzymes and cells.  The present study aims at developing an 
effective microencapsulation system for probiotics by screening and optimizing the 
factors critical to xanthan-chitosan hydrogel (XCH) capsule formation.  The changes 
in the core pH of the hydrogel capsule in response to simulated gastric juice (SGJ) 
were characterized.  Increase in xanthan concentration and chitosan molecular weight 
improved the barrier properties, however, increasing complexation time beyond 40 
min had the opposite effect.  Increase in molecular weight of chitosan resulted in 
improved viability of probiotic bacteria, Lactobacillus acidophilus, after SGJ 
treatment, which could be attributed to the differences in hydrogel membrane 
  
 
thickness at the surface of capsule, as evidenced by scanning electron micrographs 
(SEM).  Introducing XCH capsules made with high molecular weight (HMW) 
chitosan into xanthan solution resulted in the formation of xanthan-chitosan-xanthan 
hydrogel (XCXH) capsules.  Unlike HMW and medium molecular weight (MMW) 
chitosan, low molecular weight (LMW) chitosan did not form the outer layer beyond 
XCH, suggesting the significance of chitosan molecular weight in the formation of 
XCXH.  The increased hydrogel thickness of XCXH capsules formed with HMW 
chitosan compared to XCH capsules rendered better retention of cells in SGJ 
treatment for a longer period of time, further suggesting the importance of membrane 
thickness on the hydrogel stability and its barrier properties.  Furthermore, complete 
release of cells from XCXH in simulated intestinal fluid (SIF) was extended by 
approximately an hour compared to XCH capsules.  Smaller, nozzle-sprayed XCXH 
capsules using HMW chitosan protected probiotic bacteria in SGJ albeit one-log 
reduction in its protective efficacy compared to syringe extruded capsules.  When 
incorporated into stirred yogurt, XCXH microcapsules improved the viability of L. 
acidophilus by ~1 log CFU/ml between 15 and 30 days of storage.  The stability of 
bacteria against bile salts was significantly improved, enabling the delivery of 
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Chapter 1:  Introduction 
1.1 Introduction 
Gastrointestinal tract is a host for numerous bacteria that work along with the 
digestive system in delivering nutrients and chemicals that affect our body in a positive 
way (Dunne 2001; Weinbreck et al. 2010).  The microorganisms can be either beneficial 
or detrimental.  Health of an individual depends on the balance between the number of 
health beneficial and health deteriorating microorganisms colonizing in the intestine.  
Many factors such as age, diet and diseases can cause an imbalance in the intestinal 
microbiota (Fooks et al. 2001).  Dietary supplements of live bacteria that could re-
establish this balance are termed as probiotics.  Probiotics have become popular due to 
their contribution to good health by improving immune system and providing 
antipathogenic effects when consumed at large numbers (Scheinbach 1998; Kumar et al. 
2010).  However, ingestion of these bacteria will have little consequence unless enough 
probiotic bacteria reach beyond small intestine and adhere to the intestinal epithelium 
(Salminen et al. 2002). Harsh gastrointestinal conditions followed by high bile salt 
concentration often reduce the viability to levels where no health benefits are achieved.  
Microencapsulation is considered one of the effective methods that can provide 
protection against the harsh gastrointestinal conditions.  Over the years, many researchers 
have developed microencapsulation techniques to protect bacteria.  These differ in the 
kind of coating material used or technique of encapsulation.  Used mainly for 
microencapsulation of flavors and other sensitive chemicals in the food industry, 
polysaccharides such as starch and modified starches, alginate, chitosan have been 




2007; Hansen et al., 2002; Crittendon et al., 2001; Lee et al., 2004).  Although most of 
these encapsulation techniques have improved viability of probiotic bacteria in 
gastrointestinal conditions, they suffer from limitations like susceptibility to ions, low 
mechanical strength, and inability to release specifically in the intestine resulting in poor 
final effects (Kailasapathy, 2002).  Therefore, there is a pressing need for a better 
microencapsulation system to protect and deliver bacteria in intestine.  
           Xanthan and chitosan being natural biopolymers are biocompatible and non-toxic 
and are good candidates for microencapsulation of probiotics.  Xanthan, a negatively 
charged polysaccharide, forms instant hydrogels when its aqueous solution comes in 
contact with that of chitosan, a positively charged polysaccharide.  Xanthan-Chitosan 
hydrogels have been used previously for immobilization of xylanase enzyme (Dumitriu et 
al., 1994) and Corynebacterium glutamicum (Chu et al., 1997).  Xanthan in combination 
with chitosan has been demonstrated by our research group to be effective in protecting 
and releasing probiotic bacteria in gastrointestinal conditions (Argin-Soysal, 2007).  
However, reduction in capsule size showed a drastic drop in protective effects leading to 
low viability in gastrointestinal conditions. Therefore, there exists a need to optimize and 
improve the xanthan-chitosan microencapsulation system to effectively protect and 
deliver probiotic bacteria in the intestine.  
1.2 Research Objectives 
The ultimate goal of this research was to develop and optimize the 
microencapsulation system based on xanthan-chitosan polyelectrolyte hydrogel capsules 
to effectively maintain the viability of probiotic bacteria in order to confer the claimed 
health benefits. The emphasis was placed on improving the ability of the hydrogel in 




thickness on the capsules’ ability to protect probiotic bacteria was evaluated. Process 
parameters required to make small capsules to enable incorporation into foods were 
optimized. Finally the efficacy of the microencapsulation system in sustaining the 
probiotic bacteria in stirred yogurt during refrigerated storage was evaluated. The specific 
objectives directed towards this research are listed below. The subsequent chapters 
following literature review, aimed at these objectives, are presented as separate 
manuscripts. 
 
Objective 1: Evaluate the factors that affect the ability of hydrogel to retard gastric juices 
from entering the hydrogel. 
 
Objective 2: Investigate the effect of molecular weight of chitosan on the protective 
effects of hydrogel on probiotic bacteria against gastrointestinal conditions. 
 
Objective 3: Compare the effectiveness of xanthan-chitosan-xanthan hydrogel capsules in 
effectively protecting and releasing probiotic bacteria in gastrointestinal conditions to 
xanthan-chitosan hydrogel capsules. Optimize the formation of smaller capsules and 
study the effect of size on protective effects. 
 





Chapter 2:  Literature Review 
 
2.1 Human Intestinal microbiota 
The human gastrointestinal tract is a host for numerous bacteria. There is a 
considerable variability in the number of bacteria in stomach, small intestine and large 
intestine. These differences are primarily due to the availability or lack of optimum 
growth conditions that suit bacterial growth. Due to the low pH environment, the stomach 
has the lowest bacterial count usually below 10
3
 CFU/ml of gastric contents followed by 









CFU/g of gut contents (Gorbach 1967). Gut microbiota is by far 
the most complex and diverse ecosystem in our gastrointestinal tract with 300-400 
different species and thousands of strains (Guarner and Malagelada 2003; Aureli et al. 
2011). Favorable growth conditions such as pH of around 5.5 to 7 along with abundance 
in availability of undigested substrates lead to such high number of bacteria (Fooks et al. 
1999). 
Gut microbiota predominantly consists of anaerobes and include members of 
genera Bacteriosides, Bifidobacterium, Eubacterium, Clostridium, Peptococcus among 
others (Simon and Gorbach 1984; Guarner and Malagelada 2003). Bacteroides and 
Bifidobacteria account for 30 and 25% of the total anaerobic counts respectively 
(Salminen et al. 1998).  While Bacteroides like Bacteroides ovatus and Bacteroides 
fragilis, and Bifidobacteria such as B. bifidum and B. infantis predominate in the colon, 
Lactobacillus such as L. acidophilus, L. plantarum, L. casei, and L. rhamnosus are also 




The principal role of the intestinal microbiota is to metabolize carbohydrates not 
digested in the upper gut, through fermentation. The major substrates for fermentation are 
the dietary carbohydrates that have bypassed digestion. These include resistant starch, 
non-digestible oligosaccharides, cellulose, hemicelluloses, pectins, gums, and sugar 
alcohols.  In addition, some proteins like elastin, collagen, albumin as well as bacterial 
proteins released after cell lysis act as effective growth substrates for colonic bacteria. 
(Fooks et al. 1999; Salminen et al. 1998; Simon and Gorbach, 1984).  Metabolism of 
these substrates result in short chain fatty acids (SCFA) and vitamin synthesis. Among 
other functions, production of SCFA also plays part in enhanced absorption of ions such 
as calcium, magnesium and iron. However, along with the beneficial chemicals, a series 
of potentially toxic substances are also produced. These include ammonia, amines, 
phenols, thiols, and indols (Guarner and Malagelada 2003). 
The major functions of microbiota in the human intestine include providing 
barrier function by participation in the formation of the intestinal wall, immune system 
stimulation, maintenance of mucosa nutrition and circulation, production of nutrients and 
improving bioavailability, and resistance to colonization of pathogenic bacteria 
(Holzapfel and Schillinger 2002; Aureli et al. 2011).    
Intestinal microbiota of each individual has a distinctly different bacterial 
fingerprint from other individuals in a particular combination of predominant species 
(Salminen et al. 1998; Guarner 2003).  The composition of the intestinal microbiota is 
influenced by factors such as use of antibiotics, administration of drugs for treatment of 
diseases, surgical operations of the stomach or small intestine, immune disorders, stress, 




between the health beneficial and health detrimental microbiota. This delicate balance 
may be restored to normal by oral administration of probiotic bacteria. 
2.2 Probiotics  
Probiotics have been defined as “live microbial feed supplements that have 
beneficial effects on the host by improving their intestinal microbial balance” (Fuller, 
1989). The Food and Agriculture organization (FAO) of the United Nations and the 
World Health Organization (WHO) define probiotics as “Live micro organisms (bacteria 
or yeasts), which when ingested or locally applied in sufficient numbers confer one or 
more specified demonstrated health benefits for the host” (FAO/WHO, 2001).  
  The use of probiotic bacterial cultures stimulates the growth of preferred 
microorganisms, crowds out potentially harmful bacteria, improves digestion and 
reinforces the body’s natural defense mechanisms (Fooks et al. 1999; Tsuji et al. 2008; 
Aureli et al. 2011;). Other efficacies of probiotic bacteria include prevention of diarrhea 
and constipation diseases (Davidosn et al. 2000; Szajewska et al. 2006), improvement of 
lactose utilization by producing β-galactosidase (Montalto et al. 2006), nutrient synthesis 
and their bioavailability (Scheinbach 1998; Saavedra and Tschernia 2002).  In a recent 
study, administration of infant formula enriched with prebiotics, non-digestible food 
ingredients that can be utilized by microbes and stimulate their growth, like galacto- and 
fructo-oligosaccharides have shown to reduce the number of diarrheal episodes, lower the 
incidence of respiratory infections, gastroenteritis, and increase the height and weight of 
children at 3 and 6 months as compared to children fed with standard infant formula 
(Bruzzese et al. 2009). In another study involving anti-Helicobacter pylori therapy, adult 
patients showed significantly lower number of incidences of nausea, diarrhea and taste 




probiotic bacteria regulates the number of potentially harmful bacteria by several 
different mechanisms like decreasing the luminal pH by the production of short chain 
fatty acids such as acetic acid, lactic acid, or propionic acid, rendering vital nutrients 
unavailable to pathogens, altering the redox potential of the environment, producing 
hydrogen peroxide or producing bacteriocins or other inhibitory substances (Kailasapathy 
& Chin 2000; Gismondo et al. 1999). Compelling evidence for probiotic efficacy in the 
areas of improved digestion and reduced incidences of diarrhea and possibility of other 
health benefits including no risk associated with probiotic bacteria have made them an 
attractive option for improved health benefits (Sanders, 1999).  
Lactic acid bacteria (LAB) are the most important probiotic bacteria typically 
associated with the human gastrointestinal tract. Other common microorganisms are 
Bifidobacteria, Streptococcus and Enterococcus. Table 1 gives the list of species of 
bacteria used as human probiotics. The benefits of probiotics are related to the 
microorganisms which live naturally in its digestive tract (Abe et al. 1995). The natural 
adaptation of many LAB to the environment in the gastrointestinal tract and the 
antimicrobial substances produced by them (organic acids and bacteriocins) have 
provided these organisms a competitive advantage over other microorganisms to be used 
as probiotics (Salminen et al. 1998). 
The ability of probiotic microorganisms to survive and multiply in the host 
strongly influences their probiotic benefits. The bacteria should be metabolically stable 
and active in the product, survive passage through the upper digestive tract in large 






Table 2.1  Lactic acid bacteria (LAB) used as human probiotics 



















Streptococcus species thermophilus    
Enterococcus species faecium    
 
Table adapted from Klaenhammer and Kullen, 1999 
The standard for any food sold with health claims from the addition of probiotics 




 CFU of viable probiotic bacteria 
(FAO/WHO 2001). Several factors of the food that affect the viability of bacteria include 
the pH, titratable acidity, dissolved oxygen content, and storage temperature, among 
others. Furthermore, probiotic bacteria has to survive the harsh acidic conditions of 
stomach followed by a high pH and a high concentration of bile salts in the small 
intestine before it can reach the large intestine inorder to provide health benefits. (Dave 
and Shah 1997).  
Different approaches that increase the resistance of these sensitive 
microorganisms against adverse conditions have been proposed, including appropriate 
selection of acid- and bile-resistant strain, use of oxygen impermeable containers, two- 
step fermentation, and stress adaptation, incorporation of micronutrients such as peptides 
and amino acids, and microencapsulation (Gismondo et al. 1999).  While selection of 
acid and bile resistant strains, stress adaptation directly enhances the resistance of the 
bacteria, they may not be feasible to all the organisms. Microencaspulation has gained a 




been a proven technology in terms of protecting other sensitive biomaterials like 
enzymes, flavors etc. 
2.3 Microencapsulation: 
Microencapsulation is the process by which a pure material or a mixture is coated 
or entrapped into another material called wall material, membrane, carrier or shell to 
produce capsules in the micrometer to millimeter range known as microcapsules. The 
purpose of microencapsulation is to protect the functional core ingredient to be separated 
from the surrounding destructive environment until its release is desired (Anal and 
Stevens 2005). Natural examples of encapsulation include egg shells, plant seeds, 
bacterial spores (Gibbs et al. 1999). 
Microencapsulation has been used for a variety of functional materials like cells, 
enzymes, and pharmaceutical drugs, food ingredients like oleoresins, oxidation-sensitive 
vitamins, sweeteners, minerals, antioxidants and proteins (Gibbs et al. 1999; Bansode et 
al. 2010). Food and pharmaceutical industries often rely on microencapsulation 
technology for controlled release applications, enhanced stability, flavor masking, 
protection against harsh conditions, and improved nutrition (Shahidi et al. 1993; 
Schrooyen et al. 2001; Obeidat 2009). Release of the core material can be triggered by 
temperature, pH changes, osmotic shock or a combination of factors (Bansode et al. 
2010). Wall material for capsule formation utilizes a combination of one or more of 
sugars, proteins, natural and modified polysaccharides, lipids and synthetic polymers. 
Different techniques used for encapsulation include spray drying, spray chilling or 
cooling, extrusion coating, fluidized bed coating, liposome entrapment, coacervation, 




Microencapsulation of probiotic bacteria is a relatively newer technology 
developed based on cell immobilization technologies. These two technologies are 
different as they address different challenges. Immobilization of cells is applied mainly 
for bio-technological applications that require diffusion of small molecules like nutrients 
and spent molecules through the matrix. Whereas probiotics need to be isolated from the 
environment during processing/storage for better shelf life, for protection against high 
acidic stomach conditions upon ingestion and also release the bacteria in the 
gastrointestinal tract. Survival of probiotic bacteria during processing and storage can be 
affected by a range of factors including pH, post-acidification in fermented products, 
hydrogen peroxide formation, oxygen toxicity and storage temperature (Brunner et al. 
1993; Kailasapathy 2002; Anal and Singh 2007). Thus, providing probiotic bacteria with 
a physical barrier is an effective approach currently followed by many researchers.    
Table 2.2 summarizes some of the techniques used by researchers for 
encapsulating probiotic bacteria. It is evident that the ability of each system in protecting 
and delivering the bacteria is varying and each system has its own disadvantages. The 
most common system used by researchers has been alginate gum as it is very 
biocompatible, non-toxic and forms gels instantly in the presences of calcium ions and 
has high mechanical strength (Sheu et al. 1993). However, alginate gels are not stable in 
the presence of phosphate and lactate ions as these ions displace the calcium ions that are 
responsible for gelation. Hence, use of alginate has limitations considering 
microencapsulation of lactic acid bacteria and in fermented products (Kailasapathy 
2002). Also, these hydrogels may be permeable to cells (Lacroix et al. 1990). Different 
coatings and combinations of alginate gels with other polymers like starch, whey protein, 




However, each approach has its own limitations, it is important to consider the 
mechanical stability, processing conditions, storage and scale up factors along with 
protection and release of probiotics when choosing a system for microencapsulation. 
While each technology has its pros and cons, electrostatic method has gained attention 




























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































2.4 Polyionic Complexation Interactions (Electrostatic method) 
Microencapsulation by polyionic complexation involves two oppositely 
charged polymers. One acts as a core material and other acts as a coating material. 
When two polymer solutions are mixed they form an irreversible polyionic hydrogel 
because of the electrostatic interactions between the oppositely charged polymers 
(Anal and Singh 2007). Hydrogels could be water soluble or water insoluble based on 
the polymers used. Two oppositely charged polymers that are used in this project are 
xanthan and chitosan.   
2.5 Xanthan 
Xanthan gum is a high-molecular weight extracellular polysaccharide 
produced by the bacterium Xanthomonas campestris. As shown in figure 2.1, xanthan 
gum is a heteropolysaccharide with a cellulosic backbone and a trisaccharide side 
chain linked to O-3 position of every other β-D-glucose residue. Trisaccharide side 
chain consists of one D-glucuronic acid unit between two D-mannose units as shown 
in the figure. Presence of acetic acid linked to the mannose residue connecting the 
main chain and pyruvic acid linked to the terminal mannose residue makes xanthan 
gum an anionic polysaccharide. Presence of pyruvic acid at various terminal mannose 
residues is dependent on the Xanthomonas campsetris strain.  
Shear thinning behavior of xanthan is explained by association of xanthan 
chains stabilized by hydrogen bonds resulting in higher viscosity at low shear and 
reduced aggregation hence lower viscosity at high shear (Cuvelier and Launay 1986). 
Along with the marked shear thinning property, ordered helical conformation of 




is biodegradable, stable at wide range of pH and temperatures, resistant to enzymatic 
breakdown, shows synergistic properties with other natural polymers like guar gum, 
locust bean gum and galactomannans. Along with food and pharmaceutical industries, 
xanthan gum has seen applications in oil drilling, printing pastes, paints, colors, 
texture coatings and adhesives (Katzbauer 1987). 
 
 
Figure 2.1 Structure of xanthan gum 
Based on extensive research on toxicological properties and safety of xanthan 
gum for food and pharmaceutical applications, United States Food and Drug 
Administration has given xanthan a GRAS (generally regarded as safe) status without 
any specific quantity limitations. In 1980, the European Economic Community has 
added xanthan to the food emulsifier/stabilizer list, as item E-415 (Garcia et al. 2000). 
Xanthan has been used in combination with other polymers like gellan for 
immobilization of cells (Wenrong and Griffiths 2000), alginate for encapsulation of 




1997). Xanthan with its excellent properties is a good candidate for 
microencapsulation of probiotics. 
2.6 Chitosan 
 Chitosan is the deacetylated form of chitin, the most abundant natural 
biopolymer after cellulose. Chitin is a copolymer of glucosamine and N-acetyl-d-
glucosamine linked together by β(1,4) glycosidic bonds (Figure 2.2). Chitin is the 
major structural component of invertebrate exoskeletons and the cell walls of fungi 
(Shahidi et al. 1999). Chitosan is a primary aliphatic amine with a pK of 6.3 and can 
be protonated by selected acids. Chitosan is a biocompatible polymer and does not 
result in adverse reactions when in contact with human cells. Chitosan has seen many 
applications in food industry including edible film industry owing to the anti fungal 
properties of chitosan (Ghaouth et al. 1992), water purification as a chelation ion 
exchange polymer (Jeuniaux 1986), clarification and deacidification of fruit juices 
(Soto-Perlata 1996). Chitosan being a cationic polymer has pharmaceutical 
applications like nasal drug delivery agent due to its bioadhesive nature. Chitosan 
also interferes with the metabolic process of cholesterol (and other neutral lipids) by 








2.7 Xanthan-Chitosan Hydrogel 
2.7.1 Hydrogel structure & properties: 
Xanthan and chitosan being oppositely charged polysaccharides readily form 
stable hydrogels by simple complexation between amine (chitosan) and carboxylic 
(xanthan) groups in aqueous phase within wide pH range of 3.6 to 8.0 (Dumitriu et al. 
1994).  pH and degree of deacetylation of chitosan are the major factors influencing 
the ratio of xanthan to chitosan content in the hydrogel (Dumitriu et al. 1994). These 
hydrogels have open fibrillar structure with characteristic pore dimension of 100-
1000 nm and fibril diameter between 50 and 100 nm (Dumitriu et al. 1994). Chitosan-
xanthan hydrogel have a very elastic texture and high rupture strength (Mitchell 
1976).  
 Xanthan chitosan hydrogel as polyelectrolyte complexes shows pH-sensitive 
swelling behavior. pH sensitive swelling is a result of an increase in osmotic pressure. 
When hydrogel is immersed in alkaline solution, electrostatic linkage between the 
two functional groups disappears due to deionization of amino groups resulting in an 
increase in counterions (Na
+
) thus increasing osmotic pressure (Chu et al. 1995). 
While concentrations of xanthan, pH and molecular weight of chitosan were reported 
to be important factors influencing the swelling of chitosan (Argin et al. 2009; 
Dumitriu et al. 1994), complexation time was related to the permeability of surface 
membrane of the hydrogel beads, decrease in permeability was reported with 
increasing complexation time due to increase in chitosan thickness on the surface of 





2.7.2 Application of xanthan chitosan hydrogels 
Polyionic hydrogels formed by xanthan and chitosan have the advantage of 
creating a favorable ionic microsystem for stabilizing enzymes and proteins by 
interacting with the free acid and base functions (Chellat et al. 2000). In one study, 
use of xanthan chitosan hydrogel to immobilize xylanase showed over 50% increase 
in enzyme activity and workable temperatures of 80-95
0
C as compared to 50-60
0
C for 
the free enzymes (Dumitriu and Chornet 2001). High yields of immobilization 85-
98% were also achieved for xylanase enzyme (Dumitriu et al. 1994). Immobilzation 
of Corynebacterium glutamicum resulted in a 5-fold increase in its fumarase activity 
as compared to free cells and higher stability at high electrolyte concentrations for 
longer periods. 
2.7.3 Degradation  
Polymer degradation is a chain scission process that breaks polymer chains down to 
oligomers and into monomers. Degradation of polymers is an important topic of 
concern as it not only affects the release rate of the active component but also 
determines its applications based on chemical nature of the degradation products 
(Park et al. 1993). Owing to the stability of xanthan polymer in extreme pH and 
temperature conditions, along with enzyme resistance, xanthan chitosan hydrogel 
follows degradation pathway of chitosan leaving xanthan intact. Chitosan can be 
easily degraded by enzymes like lysozymes, N-acetyl-D-glucosaminidases and 
lipases (Kumar et al. 2004). One of the key factors affecting degradation is degree of 
deacetylation, with increase in degree of deacetylation degradation rate decreased 




Glucosamine (GA) and N-Acetyl-Glucosamine (NAc-GA) (Chellat et al. 2000). Both 
these products are non toxic and in vivo studies show good tolerance of these 





Chapter 3:  Assessment of xanthan-chitosan hydrogel 
composition on its internal pH stability against gastric acidity 
using fluorescence-based technique 
3.1 Introduction 
Known to destroy most viable probiotics upon digestion, the highly acidic 
gastric conditions (pH 1.5-4.0) remain a critical challenge for the food industry, since 
the desired probiotic benefits could not be achieved without delivery of sufficient 
viable cells into the small intestine (Annan et al. 2008; Gbassi et al. 2011; Shah 
2002).  It is thus crucial to develop a system capable of shielding probiotics from 
gastric acidity in order to maintain a suitable pH environment for the cells (Del Piano 
et al. 2011).  Equally noteworthy is that the system needs to properly release the cells 
upon reaching the small intestine in order for probiotics to colonize and modify the 
microbiota.  Numerous efforts have been attempted to improve the viability of 
probiotics in food products and in gastrointestinal conditions by microencapsulating 
probiotics in different wall materials, predominately starch-based (Donthidi et al. 
2010; Homayouni et al. 2008), protein-based (Doherty et al. 2011; Heidebach et al. 
2009), lipid-based (Del Piano et al. 2011; Maillard & Landuyt 2008) and alginate-
based carriers with (Chan and Zhang 2002) or without compression (Cook et al. 2011; 
Chandramouli et al. 2004; Hansen et al. 2002; Lee et al. 2004; Mokarram et al. 2009).  
While most research reported protective effects on probiotics against gastric 




evidence in the literature remains scarce on whether the cells could be properly 
released in intestinal conditions. 
Immobilization of microbial cells using polyelectrolyte complex gel 
composed of xanthan and chitosan was first reported by Chu et al. (1996) to evaluate 
the enzymatic activity of the immobilized bacteria.  In our previous research (Argin-
Soysal 2007), it was demonstrated that microencapsulation of probiotic cells using 
xanthan-chitosan hydrogel complex significantly improved their viability in gastric 
conditions and the cells could be released under intestinal conditions.  The oppositely 
charged nature of xanthan (-) and chitosan (+) due to the respective carboxylic and 
amine groups involved in the complex formed stable hydrogel immediately upon 
contact, and stayed stable under gastric conditions.  The effect of complexation 
conditions on swelling characteristics of the hydrogel has also been reported (Argin-
Soysal et al. 2009).  The maximal swelling degree of the hydrogel was reached under 
intestinal conditions, indicating its pH-sensitive nature.  It was also pointed out that 
pH and concentration effects on the xanthan–chitosan network properties are 
dependent on each other.  Therefore, it is important to optimize the hydrogel 
composition in order to provide the most stable pH environment for the encapsulated 
cells. 
It is generally recognized that the dense network structure provided by 
alginate or other hydrogels should extend the time for the acidic media to diffuse into 
the core and reach equilibrium with external pH (Amsden 1998; Anal and Singh 
2007).  However, the majority of research has been focused on the diffusion of 




(Hennink et al. 1996; Tong and Anderson 1996), and sodium and calcium ions (Chu 
et al. 1996; Graham et al. 1988) into hydrogel to provide nutrients for immobilized 
cells.  Nevertheless, only a few studies addressed the diffusion of hydrogen ion but 
were limited to gastric mucous in the stomach (Lucas 1984; Sarosiek et al. 1983).  In 
the present study, a fluorescence technique was employed to indicate the changes in 
pH inside the hydrogel with time when subjected to harsh acidic conditions.  Eosin Y, 
a water-soluble acidic dye responsive to pH changes, was used to investigate factors 
that are crucial in ushering the diffusion of acidic media into the hydrogel.  
3.2 Materials & Methods 
3.2.1. Reagents and chemicals 
Xanthan gum and chitosan, including low molecular weight (LMW, 20-200 
cP), medium molecular weight (MMW, 200-800 cP), and high molecular weight 
(HMW, 1200-1600 cP), at 75-85% deacetylation was purchased from Sigma-Aldrich 
Chemicals (St Louis, MO). Eosin Y was purchased from Acros Organics (Morris 
Plains, NJ).  Xanthan solution was prepared by dissolving predetermined amount of 
xanthan in deionized (DI) water under constant stirring.  Chitosan solution was 
prepared by dissolving known amount of chitosan in 1 N hydrochloric acid with 
heating (65-70°C for 15 min) and agitation. The pH of the clear solution was adjusted 
to 6.0 using 1 N NaOH solution and DI water was added to bring the solution to the 







3.2.2. Fluorescence technique 
3.2.2.1 Effect of xanthan concentration on Eosin Y EI signal 
To assess the effect of xanthan concentration on emission intensity (EI) signal 
of Eosin Y, solutions with different xanthan concentrations (0.7%, 1.0%, 1.2% w/v) 
with 0.01% Eosin Y were prepared.  Control was 0.01% Eosin Y in DI water. 
Aliquots (150 µl) of sample were transferred into 96-well plate and EI was measured 
on a fluorescence microplate reader (FLUOstar, BMG Labtech, Offenburg, Germany) 
with the excitation and emission wavelengths set respectively at 485 and 510 nm.  
Same wavelengths are used in all the following experiments.     
3.2.2.2. Optimal pH for eosin Y as a fluorescence indicator 
Solutions of 0.01% (w/v) eosin Y at different pH were prepared using DI 
water to identify the most acidic pH value (to simulate the gastric conditions) under 
which eosin Y could emit steady fluorescence signals.  Each eosin Y solution (150 µl) 
was added to at least 3 wells in a 96-well microplate and the EI was measured. 
3.2.2.3. Emission intensity at different hydrogel internal pH 
To assess the changes in internal pH of the hydrogel over time, various 
xanthan solutions containing 0.01% (w/v) eosin Y were prepared. Aliquots of this 
mixture (150 µl) were added to at least 3 wells in a 96-well plate before adding 100 µl 
of chitosan solution. After a predetermined complexation time, excess chitosan was 
removed by inverting the plate and tapping gently. To get rid of residual chitosan, 
each well was washed twice with pH 4.0 HCl solution to minimize swelling and 




fluorescence intensity was measured under aforementioned excitation and emission 
wavelengths.   
For experiments conducted in custom-made tubes (Figure 3.1), standard 1-mL 
pipettes were cut into 3 identical hollow tubes, each at 4 cm long, and filed to smooth 
out the edges.  Each tube was dipped into xanthan solution (1.0% w/v) until 0.02 mL 
of xanthan was inside the tube, which was then thumb-sealed at the top end before it 
was removed from the solution.  The bottom end of the tube was parafilm-sealed 
before adding chitosan solution from the other end using a Pasteur pipette to form the 
hydrogel.  After a complexation time of 40 min, unbound chitosan solution was 
removed.  The top section was replenished with 0.1 mL SGJ and parafilm-sealed, 
followed by opening of the bottom seal before the tube was attached to the side of a 
50-mL beaker containing 20 mL of 0.01% eosin Y.  After 90 min of SGJ diffusion, 
small aliquots (150 µL) of eosin Y solution were taken for fluorescence 
measurements.  The experiments were conducted in triplicates.    
                                     
Figure 3.1 Example of custom-made tube with xanthan-chitosan hydrogel (XCH) formed at the 





3.2.3 Scanning Electron Microscope (SEM)  
To provide visual confirmation of the hydrogel structure, XCH samples, after 
the prescribed complexation time, was separated from the free polymer solution and 
rinsed thoroughly with pH 4.0 solution, followed by freeze-drying for 24 hrs.  Dried 
hydrogel samples were mounted on a metal holder using double-sided tape and coated 
with Au/Pd mixture before taking SEM photographs using the SU-70 Ultra High 
Resolution Analytical SEM (Hitachi, Tokyo, Japan) at an accelerating voltage of 3 
kV.  
3.2.4. Statistical Analysis 
Emission intensity measurements were statistically analyzed using SAS 
version 9.2 (SAS Institute, Cary, NC).  Factorial analysis of variance was used to 
assess the effects of xanthan concentration, chitosan molecular weight, complexation 
time, and diffusion time on the EI of eosin Y.  Differences in least square means were 
used for pair-wise comparison of means.  Mixed procedure of SAS was used for 
analysis. 
3.3 Results & Discussion 
3.3.1 Effect of xanthan concentration on Eosin Y signal 
As seen in Figure 3.2, the xanthan concentrations investigated did not 
significantly affect the EI of eosin Y.  Eosin Y, a negatively charged pH sensitive dye 
has been used as a histological stain for decades (Waheed et al. 2000; Xie et al. 2001) 
and has recently found applications as a reagent for protein assays (Gao et al. 2007; 
Heltweg and Jung 2002; Hong et al. 1999) and as a model anionic dye in adsorption 




reported to be dependent on solvent mixtures as well as viscosity of the solvent 
(Deshpande and Iyer 1989, 1990).  However, increase in xanthan concentration from 
0.7% to 1.2% did not result in any significant differences (P>0.05) in emission 
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Figure 3.2 Effect of xanthan concentration on eosin Y emission intensity (EI) (n = 3) 
 
3.3.2 Determination of optimal eosin Y pH 
Since the typical gastric pH ranges between 1.5 and 4, it was critical to first 
profile the fluorescence of eosin Y under such conditions.  As seen in Figure 3.3, 
eosin Y fluorescence intensity (AU, arbitrary unit) between pH 2 and 4 was a 
function of pH, as the EI of eosin Y increased with increasing pH.  At pH<2, eosin Y 
was not completely soluble.  Experiments with pH 2.5 solution resulted in slightly 
less transparent hydrogel after 90 min, which could be attributed to possible phase 
separation due to chitosan degradation (Chellat et al. 2000).  Moreover, at such a low 
pH, strong protonation of xanthan’s carboxylic group could take place, which 




(1994), the yield of polyionic hydrogels obtained by complexation between xanthan 
and chitosan was significantly reduced when pH dropped to less than 2.5.  On the 
other hand, the EI changed dramatically between pH 3 and 4, rendering eosin Y too 
sensitive to pH variations within that range and thus prone to errors.  Hence, to 
simulate conditions close to gastric acidity, pH 2.75 was selected for subsequent 





























Figure 3.3 Fluorescence emission intensity (EI) of eosin Y (0.01% w/v) under different pH values 
(n=3) 
  
3.3.3 Changes in EI of eosin Y in hydrogel 
3.3.3.1. Effect of xanthan concentration and chitosan molecular weight 
The effect of xanthan concentration and chitosan molecular weight on the 
diffusion of acidic media was investigated over time (Table 3.1).  The EI was found 
to decrease with time until it reached a lower limit, followed by a steady period in all 




EI was more pronounced in the case of 0.7% xanthan compared to other 
concentrations investigated.  Xanthan at 1.2% (w/v) reached a constant level of EI in 
60 min, whereas 1.0% and 0.7% xanthan plateaued at 45 and 30 min, respectively.  
This could be attributed to the formation of less permeable hydrogel membrane due to 
elevated cross-linking density (Abubakr et al. 2010).  It could be postulated that the 
higher xanthan polymer concentration resulted in higher charge density at the point of 
contact between the two polymers, leading to improved cross-linking density.   
While the effect of chitosan molecular weight on EI of eosin Y was 
insignificant (P<0.05) in the 96-well setup (Table 3.1), it is important to note that 
such measurements were indicative of pH changes in the well. It is known that LMW 
chitosan, when acting alone, allows for higher permeability than HMW chitosan 
under same degree of deacetylation when spread and oven dried to form a membrane 
(Chen and Hwa 1996).  The authors further supported the results by measuring 
membrane crystallinity, which was found to increase with increasing chitosan 
molecular weight due possibly to higher degrees of entanglement.  Nonetheless, the 
swelling degree of hydrogels made with xanthan and LMW chitosan was significantly 
higher than that of xanthan-HMW chitosan hydrogels (Dumitriu et al. 1994), making 
it difficult to prevent eosin Y from leaking away from the hydrogel when rinsing off 
unbound chitosan.   
To further characterize the effect of chitosan molecular weight on SGJ 
diffusion, a set of custom-made pipes was employed (Figure 3.1).  Significant 
differences were found among chitosan with different molecular weights.  HMW 




Table 3.1 Variation in emission intensity (EI) of eosin Y with changes in xanthan concentration, 














                                                                                           
            Means with the same superscript are not significantly different (P > 0.05) 
   





0.7% 1.0% 1.2% 
0.7% LMW 0 48635ed 51843bdc 54873abc 
 12 33387ij 42639gf 50974dc 
 30 20047uvtrsq 25381knlm 34276i 
 45 18331uvtrws 17004uvtw 25295oknlm 
 60 17284uvtws 16075vw 20682uptrsq 
 90 16542uvtw 15871vw 18852uvtrqsw 
 120 16704uvtw 15178w 17309uvtws 
0.7% MMW 0 48964ed 50007d 55846ab 
 12 35195ih 44836ef 51526bdc 
 30 22551opnrmq 26501klm 35395ih 
 45 20002uvtrsq 20652uptrsq 26426klm 
 60 17877uvtws 17575uvtws 22895opnlmq 
 90 17306uvtws 17270uvtws 19933uvtrsq 
 120 16437uvw 16624uvtw 18274uvtrws 
0.7% HMW 0 52303bdc 55526ab 55997a 
 12 35703ih 45579ef 52331bdc 
 30 22602opnrmq 27298kl 39250gh 
 45 19214uvtrwsq 20918optrsq 29488kj 
 60 17568uvtws 18755uvtrwsq 24722oklmnq 
 90 17081uvtw 17446uvtws 21555opnrsq 




change in EI compared with the control (Figure 3.4). MMW chitosan formed a 
weaker barrier against SGJ than HMW chitosan based on the statistically significant 
difference (P<0.05) in EI, whereas LMW chitosan seemed to provide a better shield 
than MMW.  However, further increase in LMW chitosan concentration in fact 
decreased the barrier property of the hydrogel against SGJ, indicating a weakened 


































Figure 3.4 Diffusion of simulated gastric juice through xanthan-chitosan hydrogel (XCH) in tube 
(n=3) 
3.3.3.2. Effect of complexation time 
The effect of complexation time on the hydrogel ability to shield internal pH 
from external acidity variations was characterized using eosin-containing hydrogels 
formed by 1.2% xanthan and 0.7% HMW chitosan.  As seen in Figure 3.5, the EI of 
eosin Y (in percentage compared with the original EI) decreased with time in all cases 
with significant differences (p<0.05) between complexation times of 40 and 80 min.  




It is noteworthy that complexation time of 40 min appeared to be the most desirable 
profile due to the delay in the decrease in EI compared to 80 and 120 min.  This may 
be counterintuitive as longer complexation time leads to formation of thicker 
polyeletrolyte hydrogels, which results in lower permeability (Dumitriu & Chornet 
1997).  However, in the present study, with increase in complexation time, the 
hydrogel was found to shrink due possibly to the higher osmotic pressure exerted by 
the higher molar concentration of chitosan in the external solution than the xanthan 
molar concentration in the core, consequently resulting in migration of water from the 






























Figure 3.5 Diffusion profiles of eosin-containing xanthan-chitosan hydrogels (XCH) formed by 1.2% 
xanthan and 0.7% high molecular weight (HMW) chitosan at complexation times 40 (♦) , 80 (■), and 
120 min (▲) (n = 3) 
3.3.4 SEM 
SEM was used to examine the cross-section of the hydrogel.  As seen in the 
scanning electron micrographs (Fig. 3.6), the hydrogel formed using 1.0% xanthan 




xanthan and 0.7% HMW (approx. 420 nm), indicating that a longer distance existed 
in the hydrogel formed by 1.0% xanthan for acidic media (SGJ) to diffuse through.  
However, hydrogel with 1.2% xanthan showed a much more densely packed structure 
compared to 1.0% xanthan.  Increase in concentration of xanthan means increased 
number of biopolymer molecules per unit solution volume, hence the binding sites for 
chitosan also increased. Similar mechanism was suggested in case of alginate gels 
formed by reacting with CaCl2.  Increase in alginate concentration formed a thinner 
membrane compared to lower alginate concentration (Blandino et al. 2001). 
Furthermore, according to Chu et al. (1996), the hydrogel formed by xanthan and 
chitosan is considered as a porous body, and the average distance between 
neighboring crosslinks in the xanthan/chitosan gel increased as the swelling ratio 
increased.  This was further supported by Argin-Soysal et al. (2009) that xanthan 
concentration has a pronounced effect on swelling degree of xanthan/chitosan 
hydrogel.  Therefore, 1.2% xanthan contributed more barrier power to the hydrogel 
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Figure 3.6 Xanthan-chitosan hydrogel (XCH) formed by high molecular weight (HMW) chitosan with 






A fluorescence method using a pH-dependent fluorescent dye eosin Y was 
developed to study the dependency of the internal pH of xanthan-chitosan hydrogel 
on external acidity variation such as gastric acidity.  Critical factors affecting the 
formation of the hydrogel were investigated, including complexation time, molecular 
weight of chitosan, and xanthan concentration.  At 0.7% (w/v), HMW chitosan 
provided better shielding power than MMW against SGJ, while LMW chitosan 
formed a weak barrier even at elevated concentration (1.2%). Complexation time had 
significant effect on the hydrogel, with 40 min being the most effective in delaying 
acid diffusion.  Moreover, xanthan concentration was found to be the most significant 
factor affecting the barrier property of the hydrogel with minimum pH changes for 
the period of time investigated.  Such shielding power against external acidity (SGJ) 
could be attributed to the formation of a thin but dense layer at the xanthan/chitosan 




Chapter 4:  Effect of chitosan molecular weight on the survival 
of probiotics encapsulated in xanthan-chitosan hydrogel 
complex 
4.1 Introduction 
Increased concerns on whether products containing probiotics could deliver 
sufficient numbers of viable cells past harsh gastric acidity (Robinson 1991; Dave and 
Shah 1997; Ouwehand and Salminen 1998; Weese and Martin 2011) have led to vast 
movements in identifying effective mechanisms to protect the cells against processing 
conditions, storage, and through gastrointestinal tract (Shah et al. 1995; Sun and 
Griffiths 2000; Weinbreck et al. 2010) in order to exert desirable health benefits, 
including establishing balance in intestinal microbiota (Fuller 1989; Shah 2007), 
alleviating lactose intolerance (Vrese et al. 2001; He et al. 2008), providing 
anticarcinogenic effects (Wollowski et al. 2001; Kumar et al. 2010), inhibiting 
pathogenic bacteria (Chenoll et al. 2011; Vanderpool et al. 2008), and improving host 
immune system (Kailasapathy et al. 2000; El-Nezami et al. 2000; Dunne 2001). To 
date, microencapsulation of probiotic bacteria has been demonstrated to provide 
various degrees of protection (Anil and Harjinder 2007) using carriers made of starch 
(Homayouni et al. 2008; Donthidi et al. 2010), protein (Heidebach et al. 2009;  
Doherty et al. 2011), lipid (Del Piano et al. 2011; Maillard and Landuyt 2008) and 
alginate with (Chan and Zhang 2002) or without compression (Hansen et al. 2002; 
Chandramouli et al. 2004; Lee et al. 2009; Cook et al. 2011).  However, most carriers 




Skjak-Braek 1990), low mechanical strength (Buchhloz et al. 1980; Roy et al. 1987), 
and most critically inability to release probiotic bacteria in the intestine (Kailasapathy 
2002; Lee et al. 2004), resulting in poor final effects. 
Hydrogels formed by polyelectrolytic complexation between xanthan and 
chitosan have been employed to immobilize Corynebacterium glutamicum with a 
fivefold increase in enzyme activity compared to that of free cells (Chu et al. 1996), 
to encapsulate xylanase and increase its enzymatic activity by 50% (Dumitriu and 
Chornet 1997), and to protect probiotics from gastrointestinal conditions (Argin-
Soysal 2007).  The oppositely charged nature of xanthan (-) and chitosan (+) due to 
the respective carboxylic and amine groups involved in the complex formed stable 
hydrogel structure immediately upon contact, and stayed stable under gastric 
conditions.  At the intestinal pH (ca. 6.8), swelling of the hydrogel allows for the 
enzymes and bile salt in the intestinal fluid to penetrate into the gel, repelling the 
polymers, and releasing the encapsulated cells (Argin-Soysal 2007).  While xanthan-
chitosan hydrogel appears to be a promising carrier for probiotics, it must be noted 
that, besides processing conditions such as pH, polymer concentration, and 
complexation time, the hydrogel structure is dependent on inherent polymer 
parameters such as the pyruvic acid content of xanthan and the degree of 
deacetylation and molecular weight of chitosan (Dumitriu et al. 1994; Chu et al. 
1996; Dumitriu and Chornet, 1997; Magnin et al. 2004; Argin-Soysal et al. 2009). 
Known to affect the crystallinity of chitosan when forming a homopolymeric 
membrane (Chen and Hwa 1996), the molecular weight of chitosan plays an 




(Polk et al. 1994; Ribeiro et al. 1999; Lee et al. 2004).  Gåserød Sannes, and Skjåk-
Bræk (1999) reported that low molecular weight chitosan forms a porous and stable 
gel structure with negatively charged alginate.  The permeability of the chitosan-
alginate capsule could be minimized by using high molecular weight chitosan.  It has 
been demonstrated that the rigid, stereo-regular structure of chitosan can induce a 
conformational change of the other non-rigid polyelectrolyte when forming a 
polyelectrolytic gel complex with α-keratose (Park 1996), poly acrylic acid (Cerrai et 
al. 1996), xylan (Gabrielii et al. 2000) or collagen (Taravel and Domard, 1995).  
Intriguingly, when compressed into layered matrix tablets, low-molecular-weight 
chitosan (70 kDa) in combination with xanthan was found to prolong the release of 
drug extensively than using a single polymer (Phaechamud and Ritthidej, 2007), with 
visuals demonstrating the mechanical interlocking of the fibrous polymers.  The 
tablets were able to retain their gel network during dissolution, with swelling being 
the mode for releasing the core, in agreement with the findings reported by Argin-
Soysal et al. (2009).   However, the influence of chitosan molecular weight on the 
changes of hydrogel properties has not yet been elucidated.   
The primary goal of this study was to characterize the effect of chitosan molecular 
weight on the protective effects of XCH hydrogel on probiotic bacteria against 
gastrointestinal conditions.  The corresponding mechanical properties as well as the 







4.2 Materials and Methods: 
4.2.1 Materials 
Xanthan gum, chitosan at different molecular weights (high [1200-1600 cP], 
medium [200-800 cP], and low [20-200 cP]) with 75-85% deacetylation, pancreatin 
(1x USP grade) were purchased from Sigma-Aldrich Chemicals (St Louis, MO).  
Artificial gastric juice (SGJ) and simulated intestinal fluid without pancreatin were 
purchased from Fisher Scientific (Rochester, NY) and Ricca Chemicals (Arlington, 
Texas), respectively. L. acidophilus ATCC 43121 was obtained from ATCC 
(Manassas, VA).  Simulated intestinal fluid (SIF) was prepared by adding a sterile 
concentrated solution of pancreatin (sterility achieved by filtering through 0.22 µm 
sterile syringe filter) to autoclaved solution of simulated intestinal fluid to get a final 
concentration of 0.1% pancreatin. 
4.2.2 Preparation of xanthan and chitosan solutions 
To prepare 0.7%  and 1.2% (w/v) chitosan solutions, 7 and 12 g of chitosan 
were dissolved respectively in 125 ml of 1 N HCL by heating and agitation.  The pH 
of the solution was adjusted to 6.0 by drop wise addition of 1 M NaOH.  Deionized 
(DI) water was used to bring the final volume to 1 L.  Xanthan solution was prepared 
by adding known quantity of xanthan to DI water under room temperature with 
constant stirring.  Air bubbles were removed by centrifuging at 2200 rpm using 
Beckman Tj-6 centrifuge (Beckman Coulter, Fullerton, CA) (750 × g) for 10 min.  






4.2.3 Preparation of probiotic bacteria 
Active culture of L. acidophilus ATCC 43121 was maintained throughout the 
course of the experiments.  L. acidophilus ATCC 43121 was transferred twice in 
MRS broth at 37
o
C under anaerobic conditions (Anaerogen, Oxoid, Hampshire, 
England).  Culture cells were harvested after 17 hrs of incubation at 37
o
C by 
centrifugation at 10000 rpm (7000 x g) for 20 min at 4
o
C using Beckman L7-65 
ultracentrifuge (Beckman Coulter, Palo Alto, CA).  Centrifuged cells were washed 
twice and re-suspended using DI water. 
4.2.4 Encapsulation Procedure: 
Harvested and washed cell suspension was added to xanthan solution to reach 
the final concentration of 1% xanthan solution containing live cells (~10
9
 CFU/ml).  
Twenty ml of xanthan solution was extruded into 100 ml of chitosan solution by drop 
wise addition using manually operated syringe with a 0.7 mm cannula (Becton-
Dickinson, Franklin Lakes, NJ).  The capsules formed by xanthan and chitosan upon 
contact were kept in chitosan solution for 40 min at room temperature with 
continuous stirring to allow cross-linking and to avoid coalescence.  Capsules were 
filtered using a 160 µm Millipore nylon filter (Carrigtwohill, Ireland) before being 
washed using DI water.  Four sets of hydrogel capsules were prepared following the 
same procedure using 0.7% high molecular weight (HMW), 0.7% medium molecular 
weight (MMW), 0.7% low molecular weight (LMW), and 1.2% LMW chitosan.  
For freeze-dried capsules, freshly made capsules were transferred to a freeze 
drying flask and frozen using dry ice for 24 h before connecting to a freeze dryer 




depending on the amount of capsules. The mean weight of 10 freeze dried capsules 
was reported.  Experiments were replicated three times. 
4.2.5 Viability of probiotic bacteria 
4.2.5.1 Effect of chitosan on free cells 
Centrifuged and washed cell suspension was added to autoclaved chitosan 
solution (0.7% HMW, 0.7% MMW, 0.7% LMW, and 1.2% LMW) in a test tube and 
incubated at 37
o
C.  Samples were drawn at 0, 10, 20 and 40 min, diluted and plated 
on MRS agar for total plate count (CFU/ml).  Cells suspended in the same volume of 
DI water were used as the control. 
4.2.5.2 Effect of SIF on free cells 
Since SIF treatment is the critical step in releasing probiotic bacteria from the 
hydrogel, it was essential to determine its effect on the cells. Centrifuged and washed 
cell suspension was added to SIF and incubated at 37
o
C for 5 h.  Samples were taken 
at 0, 1.5, 3 and 5 h, diluted and plated on MRS agar. 
4.2.5.3 Effect of encapsulation procedure 
To study the effect of encapsulation on L. acidophilus ATCC 43121, initial 
count of the cells and final cell count of encapsulated bacteria were determined.  
Initial cell count was obtained by diluting and plating cells immediately after 
centrifugation and washing.  Cell count after encapsulation procedure was obtained 
by releasing the cells from hydrogel by suspending in SIF for 5 h.  
4.2.5.4 Simulated gastrointestinal conditions  
Filtered and washed capsules were suspended in 50 ml SGJ at pH 1.5 (pH 
adjusted using 1N NaOH) and incubated at 37
o




Capsules were filtered, washed, and transferred into SIF solution and incubated at 
37
o
C for 5 h with agitation at 150 rpm.  Sample from the SIF solution was used to 
determine the total plate count (CFU/ml) of the viable bacteria after serial dilutions.  
Experiments were replicated 4 times.  Free cells were subjected only to gastric juice 
at pH 1.5 for 1.5 h under 37
o
C. 
4.2.6 Mechanical resistance of capsules 
Mechanical resistance of capsules was measured using TA-XT2i texture 
analyzer (Texture Technologies Corporation, New York, USA).  Mechanical 
deformation tests of the xanthan-chitosan hydrogel capsules were performed by 
placing a freshly made capsule under the probe (5 Kg load cell) and measuring the 
mean bursting force at a probe speed of 0.05 mm/s until bursting was observed.  
Average bursting force of 15 capsules was reported. 
4.2.7 Cryofracturing and scanning electron microscopy 
Freshly prepared capsules were quickly frozen using liquid nitrogen.  Frozen capsules 
were fractured mechanically using a mortar and pestle under liquid nitrogen 
conditions.  Fractured frozen capsules were then freeze-dried for 24 h.  Freeze dried 
capsule particles were carefully mounted onto aluminum stub using a double sided 
tape and gold sputtered for analysis.  The SEM analysis was performed using a SU-70 
Ultra High Resolution Analytical SEM (Hitachi, Tokyo, Japan) at an accelerating 







4.2.8 Statistical Analysis 
Tests for statistical significance of differences were compared by general 
linear model (GLM) procedure of SAS. Analysis of variance and t-tests were 
performed using SAS v.9.2 (SAS Institute Inc., Cary, N.C., USA) 
4.3 Results and Discussion 
4.3.1 Viability of L. acidophilus ATCC 43121 
4.3.1.1 Effect of chitosan on free cells 
Application of chitosan as a constituent of a carrier for microbial 
encapsulation might remain doubtful because, when acting alone, chitosan does show 
antimicrobial effect against spoilage organisms (Shahidi et al. 1999; Rhodes and 
Roller 2000).  Without complexation with xanthan, chitosan at 0.7% (w/v) showed 
significant inhibition on the viability of L. acidophilus ATCC 43121 (Figure 4.1), 
with up to 4 log reduction after 40 min.  After 10 min of contacting time, 0.7% LMW 
chitosan showed the highest antimicrobial activity as evidenced by the significantly 
lower probiotic viability compared to other treatments.  The viability of L. 
acidophilus continued to decrease with increasing contacting time, and the 
differences among treatments also became less significant.   Various  mechanisms 
have been proposed in the literature on how chitosan works against specific 
components of microorganisms (Rabea et al. 2003), the most widely accepted mode  
is its interaction with cell membrane that alters cell permeability, which results in 
leakage of proteinaceous and other intracellular constituents critical for cell survival 
(Raafat et al. 2008).  Dependence of antimicrobial activity on the molecular weight of 




(1997) found that, when using fluorescence dye to label chitosan, high molecular 
weight of chitosan oligomers tend to stack to the cell wall and inhibit cell growth, 
whereas low molecular weight chitosan permeates through the cell wall and 
accelerates cell growth.  Zheng and Zhu (2003) reported that, the molecular weight 
and concentration of chitosan affects its antimicrobial activity against E. coli and S. 
aureus.  Increase in molecular weight of chitosan strengthened the antimicrobial 
effect against S. aureus whereas the antimicrobial effect weakened against E. coli.  
However, increase in concentration of chitosan resulted in increased antimicrobial 
activity in both bacteria irrespective of molecular weight.  Although Park et al. (2004) 
further indicated that increase in molecular weight of chitosan-oligosaccharides 
(COS) increased antimicrobial activity against five gram negative and five gram 
positive bacteria, it is reasonable to suggest that the molecular weight of chitosan in 
conjunction with chitosan concentration is characteristic to its antimicrobial effects 






























Figure 4.1 Effect of molecular weight of chitosan on viability of non-encapsulated L. acidophilus 
ATCC 43121 cells. Control ( ), 0.7% high molecular weight ( ), 0.7% Medium molecular weight   




4.3.1.2 Effect of encapsulation on L. acidophilus cells 
The effect of the encapsulation procedure on the viability of L. acidophilus 
ATCC 43121 is shown in Table 4.1.  Although there was a significant difference (P < 
0.05) between the initial and final cell counts after encapsulation, the decrease in 
viability was less than 1 log compared to a 4-log reduction shown with free chitosan 
solution (Figure 4.1).  The reduction in cell viability could be attributed to the effect 
of SIF during release.  As seen in Figure 4.2, L. acidophilus ATCC 43121 were fairly 
stable and resulted in less than 1-log reduction over 5 h of SIF treatment. Significant 
difference in viability of L. acidophilus was found after 1.5 h of exposure to SIF.   
Table 4.1 Effect of xanthan chitosan (XCH) encapsulation procedure on viability of L. acidophilus 
ATCC 43121. Bacteria released using simulated intestinal fluid treatment for 5 h. (n=3) 
Viability of probiotic bacteria ( log10 CFU/ml)  
Encapsulation type Initial Final 
0.7% HMW 9.26 ± 0.17 8.80 ± 0.08 
0.7% MMW 9.16 ± 0.15  8.75 ± 0.19 
0.7% LMW 9.19 ± 0.09 8.74 ± 0.10 
1.2% LMW 9.21 ± 0.10 8.79 ± 0.14 
 
These results were consistent with data from other researchers (Kim et al. 
2008; Chou and Weimer 1999).  Moreover, since the polyelectrolytic complexation 
between xanthan and chitosan is due to the interaction between their respective 
negative and positive charges, during the complexation process, the positive charges 




Therefore, the antimicrobial activity of chitosan was not a concern during 






























Figure 4.2 Viability of L. acidophilus ATCC 43121 in simulated intestinal fluid (SIF) (n=3) 
4.3.1. Effect of simulated gastrointestinal conditions on free and encapsulated 
cells  
 The effect of gastric conditions on viability of encapsulated and non-
encapsulated L. acidophilus ATCC 4312 is shown in Figure 4.3.  The initial cell 
count of harvested cells was approximately 10
9
 CFU/ml.  It is noteworthy that 
throughout the experiments the spent chitosan solution after filtration of capsules and 
wash water showed no viability of L. acidophilus ATCC 43121, suggesting no 
leakage of cells during encapsulation.  Under gastric conditions at pH 1.5 for 1.5 h, 
non-encapsulated free cells suffered approximately 5-log reduction.  On the other 




made from 0.7% HMW resulted in highest viability (>10
6
 CFU/ml).   This level of 
viability is critical as it is considered a therapeutic minimum dose to confer health 





























Figure 4.3 Viability of non-encapsulated and xanthan-chitosan encapsulated L. acidophilus ATCC 
43121 in simulated gastric juice at pH 1.5 for 1.5 h (n=4) 
Although hydrogels formed with 0.7% MMW, 0.7% LMW and 1.2% LMW gave 
statistically higher viability than free cells; substantial improvement in viability as 
compared to commonly used alginate-based microencapsulation systems was not 
achieved (Hansen et al. 2002; Mandal et al. 2006; Ding and Shah 2009).  Among all 
the combinations, 1.2% LMW resulted in least protection against SGJ followed by 
0.7% LMW.  These results are consistent with those found by Lee et al. (2004), 
where alginate beads with HMW chitosan gave higher protection against gastric 
environment compared to LMW chitosan.   The authors attributed the effect to thicker 
membranes formed by HMW chitosan with alginate.  A similar study by Polk et al. 
(1994) found that delayed release of albumin from HMW coated alginate 




compared to those formed by LMW chitosan.  In another study, alginate microspheres 
coated with HMW chitosan reached higher encapsulation yield of lipophilic drugs 
compared to LMW chitosan (Ribeiro et al. 1999).   
4.3.2 Mechanical characterization: 
 The effects of MW of chitosan on mechanical property of XCH at a constant 
complexation time of 40 min are shown in Figure 4.4.  Capsules made with 1.2% 
LMW chitosan resulted in the highest mechanical strength.  While 0.7% MMW 
chitosan formed stronger capsules than 0.7% HMW chitosan, capsules made with 
0.7% LMW chitosan showed the least resistance.  Swelling resulted in capsule size 
increase (data not shown), significantly lowered its mechanical strength due to 

















Figure 4.4 Mechanical resistance of fresh ( ) and swollen ( ) capsules with 0.7% high, 0.7% 
medium, 0.7% low and 1.2% low molecular weight of chitosan (n=3) 
The mechanical strength of polyelectrolytic capsules is dependent on factors such as 
membrane thickness (Rehor et al. 2001), membrane permeability to core contents 




thickness depends on the extent of diffusion of one polymer into the capsule core 
made of the oppositely charged polymer (Rehor et al. 2001).  Therefore, membrane 
thickness can depend on factors affecting diffusion, namely molecular weight, 
complexation time, and concentration of polymers (Bartkowiak and Hunkeler 1999; 




















Figure 4.5 Weight of freeze dried hydrogel capsules made with 0.7% high, 0.7% medium, 0.7% low, 
1.2% low molecular weight of chitosan (n=3) 
 Consistent with this theory, as seen in Figure 4.5, at constant xanthan 
concentration, decreasing molecular weight of chitosan resulted in an increase in the 
weight of the hydrogel, which suggested the presence of more chitosan in the 
hydrogel capsule possibly due to increased diffusion of chitosan into the xanthan 
core.  Furthermore, an increase in concentration of LMW chitosan from 0.7% and 
1.2% increased the hydrogel weight, indicating more diffusion of chitosan.  However, 




and 0.7% MMW chitosan.  This could be due to the formation of a very thick 
hydrogel membrane by 0.7% LMW chitosan as shown in Figure 4.6 compared to 
hydrogel membrane formed by 1.2% LMW chitosan, in agreement with study 
reported by Rehor et al. (2001) in which capsules with thicker membranes resulted in 
lower mechanical strength because the opposite membranes of the capsule touched 
before the bursting event happened.  
4.3.3 Scanning electron microscopy 
In order to study the internal structure of the XCH hydrogel capsule, the 
interior was exposed by fracturing the capsules under frozen conditions.  The external 
surface of the capsule did not show any pores (data not shown).  SEM images of the 
cross-section of the capsules showed a dense outer membrane in all combinations 
with different MW of chitosan (Figure 4.6).  The outer membrane could be the result 
of the initial polyanion/polycation interaction.  In the formation of a heteropolymeric 
capsule involving two oppositely charged polymers, it is suggested that the reaction 
in the first few minutes forms a thin outer membrane, followed by diffusion of 
polymer into the core of the capsule that forms the overall thickness of the hydrogel 
capsule membrane (Gugerli et al. 2002).  Similar explanation was given by other 
researchers in case of alginate/polylysine capsules (Bruheim et al. 1996; Gugerili et 





         
                                (a)           (b) 
Figure 4.6 Scanning electron microscope images of the porous structure formed by (a) 0.7% low 
molecular weight chitosan and (b) 1.2% low molecular weight chitosan 
In the present study, a porous structure was only observed in case of LMW 
chitosan, indicating diffusion of chitosan chains into the capsule after the formation 
of the initial outer layer.   Furthermore, the porous structure formed by 1.2 % LMW 
appeared to be sandwiched between an outer membrane and a second dense 
membrane (Figure 4.6), whereas porous structure formed by 0.7% LMW did not have 
the second dense membrane and continued deep into the capsule.  The higher osmotic 
pressure in case of 1.2% LMW may have resulted in the formation of the sandwich 
structure.  The osmotic pressure difference could be attributed to the difference in 
molar concentrations of chitosan and xanthan solutions.  The thickness of the outer 
membrane correlated directly with the molecular weight of chitosan. Outer membrane 
with highest thickness was formed with 0.7% HMW and least thickness with 0.7 and 
1.2% LMW chitosan.  This is consistent with one study, in which thickness of films 
formed by mixing chitosan and alginate was affected by molecular weight of chitosan 
where higher molecular weight resulted in thicker film than medium and low 





Figure 4.7 Scanning electron microscope images of cross section of freeze dried hydrogels. Hydrogel 
formed with (a) 0.7% high molecular weight chitosan, (b) 0.7% medium molecular weight chitosan, (c) 
0.7% low molecular weight chitosan, (d) 1.2% low molecular weight chitosan 
on the protective effects of XCH hydrogels and the SEM cross-sectional observation 
of the hydrogel containing encapsulated L. acidophilus cells, it can be summarized 
that the outer membrane (Figure 6) may be critical in providing the barrier properties 
to the capsule, resulting in enhanced viability of L. acidophilus ATCC 43121 against 
harsh gastrointestinal solutions.  
4.4 Conclusion 
 Microencapsulation of probiotics using XCH hydrogels significantly 
improved the viability of L. acidophilus ATCC 43121 in simulated gastrointestinal 







viability of free cells, it did not have any effect on encapsulated bacteria after forming 
the hydrogel with xanthan.  Mechanical resistance of hydrogel capsules varied 
significantly with chitosan molecular weight, with 1.2% LMW chitosan forming the 
strongest capsules.  SEM images revealed major differences in hydrogel structure in 
response to different chitosan molecular weight and concentration.  LMW chitosan 
formed a porous structure and a sandwich structure at elevated concentration.  A 
positive correlation between molecular weight of chitosan and the outer membrane of 
the capsules was observed.  The thickness of outer membrane may be the key in 
protecting L. acidophilus ATCC 43121 against simulated gastric juice and can be a 
critical factor when further optimizing XCH hydrogels for effective 
microencapsulation of probiotics bacteria.  
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Chapter 5:  Effect of xanthan/chitosan/xanthan encapsulation 
and capsule size on survival of Lactobacillus acidophilus ATCC 
43121 in simulated gastrointestinal conditions 
5.1 Introduction 
Probiotics are live microorganisms proven to provide number of health 
benefits like improving immune system, reducing lactose intolerance and providing 
anti-pathogenic effects when consumed at a therapeutic minimum of 10
6
 per gram of 
food.  However, probiotics are susceptible to various factors like processing 
conditions, storage, and most importantly the harsh gastrointestinal conditions. 
Microencapsulation of probiotics has received a great deal of attention in the recent 
past due to its ability to protect probiotic cells in gastrointestinal conditions. Many 
microencapsulation systems based on various carriers made of alginate, starch, 
protein, lipid have been developed (Hansen et al. 2002; Chandramouli et al. 2004; 
Lee et al. 2004; Mokarram et al. 2009; Cook et al. 2011; Heidebach et al. 2009;  Del 
Piano et al. 2011; Doherty et al. 2011).  However, most carriers suffer from one or 
more limitations such as susceptibility to ions (Smidsrod and Skjak-Braek 1990), low 
mechanical strength (Buchhloz et al. 1980; Roy et al. 1987), and most critically 
inability to release probiotic bacteria in the intestine (Kailasapathy 2002; Lee et al. 
2004), resulting in poor final effects. 
Hydrogels formed by xanthan and chitosan by polyelectrolytic complexation 
have been applied to immobilize Corynebacterium glutamicum (Chu et al. 1996), to 




gastrointestinal conditions (Argin-Soysal 2007).  The oppositely charged nature of 
xanthan (-) and chitosan (+) form polyelectrolytic hydrogel structure immediately 
upon contact and remained stayed stable under gastric conditions (pH 2.0) and 
effectively released at intestinal pH (ca. 6.8) (Argin-Soysal 2007) While xanthan-
chitosan hydrogel (XCH) has effectively protected probiotic bacteria in 
gastrointestinal conditions, reduction is capsule size showed drastic fall in protective 
effects leading to low viability in gastrointestinal conditions.  The protective effects 
of XCH could possibly be improved if the thickness of the capsule is increased by 
formation of an extra layer of hydrogel.  
     The formation of successive layers of hydrogel to increase the thickness of 
capsules and to fine tune properties of capsule has been done with various natural 
polymer systems like chitosan/chitosan sulfate (Berth et al. 2002), poly(DL-lactic 
acid)/poly(DL-lactic-co-glycolic acid) (Shenoy et al. 2003), chondrotin sulfate/poly(L-
arginine) (Shchukin et al. 2004), dextran sulfate/protamine (Balabushevich et al. 
2003), poly(L-lysine)/poly(glutamic acid) (Yu et al. 2005).  The driving forces for 
formation of extra layers are the electrostatic interaction between adjacent layers and 
entropy increase upon capsule formation (Antipov and Sukhorukov, 2004).  In one 
study, the multilayer capsules made by Schneider et al. (2001) for encapsulating 
pancreatic islets were found advantageous in protecting the core over capsules made 
by a single-step procedure. Namely, the multilayer capsules made by suspending 
sodium alginate beads in a series of polyanion and polycation solutions resulted in 
high mechanical stability and physical integrity with precise permeability while 




further improved the alginate beads containing probiotic bacteria by coating them 
with alginate to form a second and third layers that resulted in better protection 
against gastric conditions, suggesting that the permeability of a capsule is dependent 
on the thickness, porosity, and structure of the layers present (Antipov and 
Sukhorukov 2004, Johnston et al. 2006).  While the protective effects of XCH on 
probiotic cells have been characterized in Chapter 4, the effect of an extra layer of 
hydrogel outside XCH remained to be explored. 
The primary goal of this study was to characterize the protective effects of 
xanthan-chitosan-xanthan (XCXH) at different sizes compared to xanthan-chitosan 
hydrogel (XCH) on probiotic cells against gastrointestinal conditions.  The release 
properties of XCXH and XCX and the corresponding microstructure of the hydrogels 
were also elucidated.   
5.2 Materials and Methods: 
5.2.1 Materials 
Xanthan gum, chitosan at different molecular weights (high [1200-1600 cP], 
medium [200-800 cP], and low [20-200 cP]), pancreatin (1x USP grade) were 
purchased from Sigma-Aldrich Chemicals (St Louis, MO).  Simulated gastric juice 
(SGJ) and simulated intestinal fluid without pancreatin were purchased from Fisher 
Scientific (Rochester, NY) and Ricca Chemicals (Arlington, TX), respectively. L. 
acidophilus ATCC 43121 was obtained from ATCC (Manassas, VA).  Simulated 
intestinal fluid (SIF) was prepared by adding a sterile concentrated solution of 




autoclaved solution of simulated intestinal fluid to get a final concentration of 0.1% 
pancreatin. 
5.2.2 Preparation of xanthan and chitosan solutions 
Chitosan solution was prepared by dissolving known quantity of chitosan in 
125 ml of 1 N HCL by heating and agitation.  The pH of the solution was adjusted to 
6.0 by drop wise addition of 1 M NaOH.  Deionized (DI) water was used to bring the 
final volume to 1 L.  Xanthan solution was prepared by adding known quantity of 
xanthan to DI water under room temperature with constant stirring.  Air bubbles were 
removed by centrifuging at 2200 rpm using Beckman Tj-6 centrifuge (Beckman 
Coulter, Fullerton, CA) (750 ×g) for 10 min.  Xanthan and chitosan solutions were 
autoclaved before encapsulation procedures. 
5.2.3 Preparation of probiotic bacteria 
Active culture of L. acidophilus ATCC 43121 was maintained throughout the 
course of the experiments.  L. acidophilus ATCC 43121 was transferred twice in 
MRS broth at 37
o
C under anaerobic conditions (Anaerogen, Oxoid, Hampshire, 
England).  Culture cells were harvested after 17 hrs of incubation at 37
o
C by 
centrifugation at 10000 rpm (7000 x g) for 20 min at 4
o
C using Beckman L7-65 
ultracentrifuge (Beckman Coulter, Palo Alto, CA).  Centrifuged cells were washed 
twice and re-suspended using DI water. 
5.2.4 Encapsulation Procedure 
5.2.4.1 Syringe extruded capsules 
Harvested and washed L. acidophilus cell suspension was added to xanthan 






CFU/ml live cells.  The solution was then extruded into 0.7% HMW chitosan solution 
by dropwise addition using manually operated syringe with a 0.7 mm cannula 
(Becton-Dickinson, Franklin Lakes, NJ).  The capsules formed by xanthan and 
chitosan (XCH) upon contact were kept in chitosan solution for 40 min at room 
temperature with continuous stirring to allow cross-linking and to avoid coalescence.  
Capsules were filtered using a 160 µm Millipore nylon filter (Carrigtwohill, Ireland) 
before being washed using DI water.  XCXH capsules were made by suspending the 
XCH capsules into 0.1% xanthan solution for 30 min with continuous agitation 
followed by filtration and washing using DI water. 
5.2.4.2 Spray-nozzle extruded capsules 
Xanthan solution (1%, w/v) containing viable cells (~10
9 
CFU/ml) was extruded into 
0.7% HMW chitosan solution through a 0.7 mm nozzle using a Büchi B-290 mini 
spray dryer (Büchi, Flawil, Switzerland).  Specifications of the encapsulation 
conditions are shown in Figure 1a.  Air flow rate of 246 L/h and the feed pump rate of 
3.6 ml xanthan/min into chitosan solution (300 ml) with constant stirring resulted in 
well defined hydrogel capsules (<500 µm) with no coalescence (Figure 1b).  The 
capsules were kept in chitosan solution for 40 min at room temperature with 
continuous stirring to allow cross-linking.  Capsules were filtered using a 100 µm 
Millipore nylon filter (Carrigtwohill, Ireland) before being washed using DI water.  
Washed and filtered capsules were dispersed into 0.1% xanthan solution with 
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Figure 5.1 (a) Microencapsulation setup using spray nozzle. (b) XCXH microcapsules (dyed with 
eosin to visualize) formed by spray nozzle (The ruler shown is at the scale of 15 mm or 0.6 inch).   
5.2.5 Viability of probiotic bacteria in gastrointestinal conditions 
Filtered and washed capsules were suspended in 50 ml SGJ at pH 1.5 (pH 
adjusted using 1N NaOH) and incubated at 37
o
C for 1.5 h with agitation at 150 rpm.  
Capsules were filtered, washed, and transferred into SIF solution and incubated at 
37
o
C for 5 h with agitation at 150 rpm.  Sample from the SIF solution was used for 
total plate count (CFU/ml) of viable bacteria after serial dilutions.  Experiments were 
conducted in quadruplicates. 
5.2.6   Release of probiotic bacteria in gastrointestinal conditions 
Freshly prepared capsules were suspended in 50 ml SGJ for 1.5 h followed by 
150 ml SIF for 5 h.  The cell concentration was monitored over time by periodical 
sampling with optical density (OD) measurements taken at 600 nm using a Helios 
17.5 cm 
300 ml of 
0.7% HMW Chitosan solution 





spectrophotometer (Thermospectronic, Rochester, NY). Optical density was 
converted into corresponding concentration (g/l) based on a calibration curve. To 
construct a calibration curve, optical densities of various dilutions of L. acidophilus 
cells were measured and plotted against the corresponding dry weight of the cells 
obtained after oven drying the samples for 24 h.  
5.2.7 Cryofracturing and scanning electron microscopy 
Four sets of syringe-extruded XCXH capsules were prepared following the 
same procedure using 0.7% high molecular weight (HMW), 0.7% medium molecular 
weight (MMW), 0.7% low molecular weight (LMW), and 1.2% LMW chitosan.  
Freshly prepared capsules were quickly frozen using liquid nitrogen.  Cryofracturing 
of the frozen capsules were conducted mechanically using a mortar and pestle under 
liquid nitrogen conditions.  Fractured frozen capsules were then freeze-dried for 24 h 
before carefully mounted onto an aluminum stub using a double sided tape and gold 
sputtered prior to analysis.  The SEM analysis was performed using a SU-70 Ultra 
High Resolution Analytical SEM (Hitachi, Tokyo, Japan) at an accelerating voltage 
of 5 kV. 
5.2.8 Statistical Analysis 
Tests for statistical significance of differences between cell counts were 
compared by general linear model (GLM) procedure of SAS. Analysis of variance 







5.3 Results and Discussion 
5.3.1 Calibration curve 
As seen in figure 5.2, the optical density of L. acidophilus ATCC 43121 cells 


















Figure 5.2 Calibration curve of L. acidophilus ATCC 43121 
5.3.1 Release of L. acidophilus in gastrointestinal conditions 
Figure 5.3 shows the amount of cells released from XCH- and XCXH-encapsulated 
probiotics after SGJ (pH 1.5) treatment.  While XCXH capsules remained stable and 
retained bacteria for approximately 3 h without any release, XCH capsules started 
releasing cells at approximately 40 min.  This could be due to damage of the XCH 
hydrogel membrane in harsh gastric environment.  It should be noted that xanthan is a 
resilient molecule known to possess ordered conformation and stabilizing forces 
between the strands (Katzbauer 1998).  However, on the other hand, chitosan is very 
susceptible to depolymerization due possibly to hydrolysis of the O-glycosidic 
linkages and the N-acetyl linkages as seen in dilute and concentrated HCl solutions 





























Figure 5.3 Release of L. acidophilus ATCC 43121 cells from xanthan-chitosan hydrogel (XCH, ♦) and 
xanthan-chitosan-xanthan hydrogel (XCXH, ) capsules in simulated gastric juice at pH 1.5 (n = 2) 
 
harsh SGJ conditions could be attributed to the presence of acid-susceptible chitosan 
at the surface of XCX, unlike acid-resistant xanthan at the surface of XCXH. 
The ability of a microencapsulation system to release the probiotic bacteria in 
intestinal conditions is critical in ushering the efficacy of probiotic bacteria to confer 
desirable health benefits.  Figure 5.4 shows the fractional release of probiotic bacteria 
subjected to sequential SGJ and SIF treatments.  After SGJ treatment at pH 1.5 for 1.5 
h, both XCH and XCXH were able to release the encapsulated cells shortly after 
transfer to SIF.  While XCH reached the maximum release at 5 h, XCXH took up to 6 
h.  This difference could be due to the presence of already damaged XCH capsules in 
SGJ that led to faster release in SIF compared to XCXH.  Furthermore, it could also 
be due to the differences in hydrogel membrane thickness between XCH and XCXH.  
XCH are known to exhibit diffusion-controlled release of its core contents under 




mention that chitosan is susceptible to enzymetic depolymerization (Muzzarelli 1997) 



















Figure 5.4 Fractional release of Lactobacillus acidophilus ATCC 43121 cells from  xanthan-chitosan 
hydrogel (XCH, ♦) and xanthan-chitosan-xanthan hydrogel (XCXH, ) in simulated gastric juice 
(SGJ) at pH 1.5 and in simulated intestinal fluid (SIF) at pH 6.8 (n = 3) 
 
5.3.2 Effect of simulated gastrointestinal conditions on encapsulated cells  
 The effect of simulated gastric conditions on the viability of encapsulated and 
non-encapsulated L. acidophilus ATCC 4312 is shown in Figure 5.5.  The initial cell 
count of harvested cells was approximately 10
9
 CFU/ml.  Under gastric conditions at 
pH 1.5 for 1.5 h, non-encapsulated free cells suffered ca. 5-log reduction.  On the 
other hand, encapsulated cells retained significantly higher viability in all cases.  
Syringe extruded XCXH capsules (2-3 mm) resulted in at least 1.5 log CFU/ml more 
viable cells than those in XCH capsules.  Smaller capsules (<500 µm) produced using 




capsules and was not significantly different from those in XCH capsules.  The 
differences in the protective effects of XCXH and XCH could be a combination of 
two effects.  First, the ability of XCXH to retain probiotic bacteria in SGJ at pH 1.5 
for 1.5 h without any leakage was superior to XCH capsules, which released probiotic 
bacteria after only 40 min of SGJ treatment.  Second, the extra layer of xanthan 
coated on the surface of XCXH means formation of thicker hydrogel membrane, 
which corresponds to more time it takes for the core of the capsule to reach pH 


































Figure 5.5 Viability of non-encapsulated and encapsulated (syringe extruded XCH, XCXH and air 
atomized XCXH) Lactobacillus acidophilus ATCC 43121 in simulated gastric juice at pH 1.5 for 1.5 h 
followed by releasing in simulated intestinal fluid for 5 h (n=4). 
 Although XCXH syringe-extruded capsules gave better protection than XCH 
capsules in SGJ (Figure 5.5), the protective effects decreased when the size of the 
capsules decreased.  Many researchers have reported similar findings (Sheu et al. 
1993; Lee and Heo 2000; Argin-Soysal 2007).  In one such study, Chandramouli et 
al. (2004) reported that the viability of encapsulated Lactobacillus in simulated 




permeation of gastric fluid into the hydrogels is the primary purpose of 
microencapsulation for probiotics (Anal and Singh 2007), the smaller sized capsules 
may have resulted in lower protective effects due to the reduced time it takes for the 
core of the capsule to reach gastric pH compared to bigger capsules.  Nevertheless, 
smaller XCXH capsules resulted in a level of viability (ca. 10
6
 CFU/ml) that is 
critical to be considered a therapeutic minimum dose to confer health benefits to the 
consumer (Robinson 1991; Ouwehand and Salminen 1998).  
5.3.3 Scanning electron microscopy 
The internal structure of the XCXH hydrogel was exposed by fracturing the capsules 
under frozen conditions for observation using SEM.  XCXH capsules formed with 0.7 
% HMW chitosan showed a very thick shell formation (Figure 5.6 a).  Probiotic cells 
were observed in the core of the capsule adhered to xanthan polymer (Figure 5.6 b) 
and also entrapped inside the capsule wall (Figure 5.6 c).  The thickness of the XCXH 
hydrogel shell was considerably increased compared to thickness of XCH hydrogel 
membrane (Figure 4.7a).  While thickness of XCXH formed by 0.7% MMW chitosan 
(Figure 5.6 d) also increased considerably, it formed a more porous structure than 
0.7% HMW chitosan.   XCXH capsules formed with 0.7% LMW chitosan (Figure 5.6 
e) did not show any changes compared to XCH (Figure 4.7c) and retained a highly 
porous structure (Figure 5.6 f).  However, XCXH using 1.2% LMW chitosan (Figure 
5.6 g) showed a loosely attached hydrogel layer possibly due to the formation of 
hydrogel between xanthan and residual unattached chitosan on the capsule surface.  
Internal structure remained porous, similar to XCXH formed with 0.7% LMW.  The 
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Figure 5.6 Scanning electron microscope images of cross section of freeze dried hydrogels. Xanthan-
chitosan-xanthan hydrogel (XCXH) formed with 0.7% high molecular weight chitosan: (a) 800×, (b) 
core at 6000×, and (c) shell at 3000×; with 0.7% medium molecular weight chitosan: (d) 2500×; with 
0.7% low molecular weight chitosan: (e) 1100× showing no distinct outer layer and (f) 10000×; and 
with 1.2% low molecular weight chitosan: (g) 1200× showing a loose outer layer and (h) 9000×. 
 
the surface of XCXH formed by 0.7% LMW and 1.2% LMW, respectively, suggests 
that there is not enough chitosan on the surface after formation of XCH to bind to 
surrounding xanthan for the second layer to form.  This might expose more pores on 
the surface of the capsule, hindering the hydrogel’s ability in retarding gastric fluid, 
and consequently affecting the protective effect of the capsules adversely.  
5.4 Conclusion 
 Microencapsulation of probiotics using XCXH hydrogels significantly 
improved the viability of L. acidophilus ATCC 43121 in SGJ at pH 1.5 for 1.5 h 
compared to XCH capsules. Reduction in the size of XCXH capsules by air 
atomization resulted in significantly lower viability compared to syringe extruded 
capsules; however the viability was significantly higher than free cells in SGJ. XCXH 




XCH capsule lost its integrity after 40 min.  XCXH capsules took longer 
(approximately 1h) to release all cells in SIF compared to XCH.  Scanning electron 
micrographs revealed that HMW and MMW chitosan formed thicker hydrogel 
membranes compared to XCH, while LMW chitosan did not form a firm extra layer.  
This suggests that the key parameter, namely chitosan molecular weight that affects 
XCH cross-linking during capsule formation is also critical for the formation of 
XCXH capsules.  
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 Chapter 6: Survival of xanthan-chitosan-xanthan 
microencapsulated Lactobacillus acidophilus ATCC 43121 in 
stirred yogurt during refrigerated storage 
6.1 Introduction 
Yogurt is one of the widely consumed foods throughout the world with an 
established market as a functional therapeutic food (Samona and Robinson 1994; 
Sarkar, 2008).  Yogurt has been the simplest form of preservation for milk since long 
ages.  Elie Metchinkoff, a scientist from early 20
th
 century was the first to postulate 
the health benefits of yogurt related to the extraordinary longevity of Bulgarians 
(Metchinkoff, 1908). The normal yogurt cultures, Lactobacillus delbrueckii ssp. 
Bulgaricus and Streptococcus thermophilus, cannot survive and grow in the intestinal 
tract due to poor bile salt tolerance. Many different microorganisms are added to 
dairy products including yogurt to enhance their probiotic potential (Fuller, 1997; 
Bhadoria and Mahaputra, 2011).  However, retaining the viability of probiotic 
bacteria has long been a challenge and studies have shown that a lot of the 
commercial products do not contain the prescribed number of live probiotic bacteria 
at the time of consumption. In one study, Shah (2000) studied the viability of L. casei 
content in commercial yogurts and found no traces of live microorganisms in 3 of 6 
products tested and only low concentrations in two others. In another study, Huges 
and Hoover (1991) analyzed 11 products claiming to contain L. acidophilus, of those 
only two products contained live bacteria.  The reduction in viability of probiotic 




acidification due to residual fermentation during storage, stability in dried or frozen 
form, and incompatibility with traditional starter culture during fermentation (Anal et 
al. 2007; Kailasapathy 2002; Brunner et al. 1993; Shah 2000). In addition, the harsh 
gastrointestinal conditions, namely high acidity of gastric juices in stomach followed 
by high bile concentration further reduces the number of probiotic bacteria before 
they can reach the large intestine and colonize.  
Microencapsulation is the most commonly used method by researchers to improve 
viability of probiotic bacteria during storage and during transit through 
gastrointestinal tract. Numerous efforts have been attempted to improve the viability 
of probiotics in yogurt and other fermented and non-fermented dairy products by 
microencapsulating probiotics in various wall materials, predominately alginate-based 
(Sheu and Marshall 1993; Kebary et al. 1998; Chandramouli, 2004; Brinques 2011), 
cellulose acetate phthalate (Rao et al. 1989), carrageenan (Adhikari et al 2003), 
gelatin (Hyndman 1993), and whey protein based (Picot and Lacroix 2004) 
encapsulation. While most research reported protective effects on probiotics during 
storage conditions and some during gastric transit, they suffer from one or more 
limitations including low stability in the presence of chelating agents such as 
phosphate, lactate and citrate (Smidsrod and Skjak-Braek 1990). Furthermore, 
evidence in the literature remains scarce on whether the cells could be properly 
released in intestinal conditions (Kailasapathy 2002; Lee et al. 2004). 
In our previous research (Argin-Soysal, 2007), it was demonstrated that 
microencapsulation of probiotic cells using xanthan-chitosan hydrogel complex 




released under intestinal conditions.  The oppositely charged nature of xanthan (-) and 
chitosan (+) due to the respective carboxylic and amine groups formed xanthan –
chitosan  polyelectrolytic hydrogel complex immediately upon contact, and stayed 
stable under gastric conditions. However, the efficacy of these hydrogels has not been 
evaluated in food systems. Therefore, the main objective of this study was to study 
the effect of xanthan chitosan-xanthan hydrogel encapsulated L. acidophilus ATCC 
43121 in stirred yogurt at refrigerated storage.  
6.2 Materials & Methods 
6.2.1. Reagents and chemicals 
Xanthan gum and high molecular weight (HMW, 1200-1600 cP), at 75% 
deacetylation was purchased from Sigma-Aldrich Chemicals (St Louis, MO). 
Yogourmet (Lyo-San Inc., Lachute, Cabada), a commercial freeze dried yogurt starter 
(L. bulgaricus, S. thermophilus, L. acidophilus), was purchased. Artificial intestinal 
fluid without pancreatin was purchased from Fisher Ricca Chemicals (Arlington, 
Texas), respectively. L. acidophilus ATCC 43121 was obtained from ATCC 
(Manassas, VA).  Simulated intestinal fluid (SIF) was prepared by adding a sterile 
concentrated solution of pancreatin (sterility achieved by filtering through 0.22 µm 
sterile syringe filter) to autoclaved solution containing artificial intestinal fluid to 
reach a final concentration of 0.1% pancreatin. 
6.2.2. Microencapsulation procedure 
Lactobacillus acidophilus ATCC 43121 cells were encapsulated in triple layer 
spray-nozzle extruded capsules as described in Chapter 5. 




Two percent skimmed milk was pasteurized using a water bath at 85
o
C for 30 
min.  It was cooled to 43
o
C and inoculated with 2.5 g of starter culture already 
suspended in 10 ml of pasteurized 2% skimmed milk pre-cooled to 43
o
C.  The 
mixture was shaken thoroughly and incubated for 4 h at 43
o
C until the pH of yogurt 
reached 4.6.  Yogurt was stirred at 700 rpm for 10 min to obtain a smooth liquid like 
consistency followed by pasteurization (85
o
C for 30 min) and cooling.  Stirred 
yogurts containing either free or encapsulated L. acidophilus cells were prepared by 
respectively adding the free cell suspension or encapsulated L. acidophilus to stirred 
yogurt respectively. Yogurts were then stirred at 500 rpm for 10 min to disperse free 
cells or capsules uniformly.  A fixed volume (10 ml) of stirred yogurts (containing 
free cells and encapsulated cells) were dispensed into several sterilized test tubes and 
stored at 4
o
C for storage studies. For pH measurements, 200 ml of stirred yogurt was 
stored in sterilized beaker at 4
o
C. Experiments were conducted in triplicates. 
6.2.4 Release and enumeration of bacteria 
Two 10 ml yogurt samples from each batch (encapsulated and non-
encapsulated L. acidopjhilus) were analyzed for viability of probiotic bacteria every 5 
days during the 45 days of storage period. For stirred yogurt containing 
microcapsules, sample was added to 100 ml of SIF containing 0.1% pancreatin for 5 
hours at 35
o
C to release cells from microcapsules, followed by enumeration by serial 
dilution and plating on MRS agar. For stirred yogurt with non-encapsulated cells, 
sample was directly diluted using DI water and plated on MRS agar for plate count. 
To observe the effect of SIF on non-encapsulated cells in stirred yogurt, sample was 
added to 100 ml of SIF and incubated at 35
o




on MRS agar. The number of viable cells was obtained after incubation of plates for 
48 hours in anaerobic conditions.  
6.2.5. Statistical Analysis 
Tests for statistical significance of differences were compared by general 
linear model (GLM) procedure of SAS. Analysis of variance and t-tests were 
performed using SAS v.9.2 (SAS Institute Inc., Cary, N.C., USA) 
6.3. Results & Discussion 
The pH of yogurt (Figure 6.1) with free L. acidophilus cells was slightly 
higher than pH of yogurt with encapsulated cells possibly due to differences in the pH 
of free cell suspension and microcapsule suspension before addition to yogurt. Yogurt 
with free cells had significantly higher pH until 5 days of storage and the differences 














Figure 6.1 Changes in pH of yogurt with free (♦) and xanthan-chitosan-xanthan hydrogel (XCXH) 





The number of L. acidophilus ATCC 43121 cells, both encapsulated and non-
encapsulated, in stirred yogurt declined with storage time at refrigerated temperature 



























Figure 6.2 Effect of refrigerated storage time on viability of Lactobacillus acidophilus ATCC. 
Xanthan-chitosan-xanthan hydrogel (XCXH) microencapsulated cells released by 5 h simulated  
intestinal fluid (SIF) treatment (); Free cells (♦); Free cells after 5 h SIF treatment () 
 
Encapsulated L. acidophilus ATCC 43121 retained significantly higher viability 
starting from day 15 until day 45 except day 35.  However, it must be emphasized 
that the encapsulated cells were subjected to a 5 h SIF treatment to release them from 
XCXH microcapsules. When compared to free cells subjected to 5 h SIF treatment, 
encapsulated cells retained significantly higher viability (1 to 2 log CFU/ml) during 
the entire storage period.  Free cells from yogurt subjected to SIF resulted in less than 
10
6
 CFU/ml after only 10 days of storage. However encapsulation maintained the 
viability of 10
6
 CFU/ml, a therapeutic minimum to achieve health benefits, until 25 
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Figure 6.3 MRS agar plates with cells incubated for 48 hrs at 35
o
C. Freshly harvested cells from MRS 
broth (a), cells released from xanthan-chitosan-xanthan hydrogel (XCXH) capsules in yogurt after 5h 
simulated intestinal fluid (SIF) treatment (b), free cells from yogurt (c), free cells from yogurt after 5 h 
SIF treatment (d). Dilutions made before plating are different for each of the treatments. 
 
The colonies formed by L. acidophilus ATCC 4312 are shown in Figure 6.3.  
Encapsulated cells after release formed circular, smooth edged colonies similar to 
those from freshly harvested cells after fermentation.  While free cells from yogurt 
did not show healthy growth of colonies indicating cell damage, free cells after 5 h 
SIF treatment formed two different types of colonies one similar to encapsulated cell 
but smaller in size and other with large, irregular, rough edged colonies.  The 




or bile resistance of the bacteria. Klaenhammer and Kleeman (1981) reported that the 
differences in morphology of Lactobacillus acidophilus colonies were not a result of 
genetic variability but a phenotypic variability caused by environmental factors. 
According to Suskovi et al. (2000), differences in bile resistance of Lactobacillus 
acidophilus M92 resulted in two distinct types of colonies with different 
morphological characteristics. It is worth mentioning that L. acidophilus ATCC 
43121 cells are bile resistant as evidenced by only a slight decrease in viability after 5 
h of SIF treatment (Figure 4.2). However, a decreased bile resistance is noticed when 
added to yogurt with a loss of at least 2 logs CFU/ml during refrigerated storage 
indicating a change in bile resistance possibly due to extended exposure to low pH of 
yogurt.    
4. Conclusion 
The numbers of both encapsulated and non-encapsulated Lactobacillus 
acidophilus ATCC 43131 bacteria added to yogurt declined with storage time at 
refrigerated conditions. Xanthan-chitosan-xanthan hydrogels resulted in significant 
improvement in probiotic viability compared to non-encapsulated cells. Non-
encapsulated cells in yogurt when subject to SIF declined in viability indicating a loss 
in bile resistance supported by changes in morphological characteristics of cell 
colonies.  Encapsulated bacteria formed regular colonies and resulted in viability 
above the therapeutic minimum (>10
6 
CFU/g) thus promising to deliver enough 





Chapter 7: Conclusions and Recommendations 
Xanthan chitosan hydrogel formed stable hydrogels capable of protecting 
probiotic bacteria against gastric conditions. Factors affecting the protective effects of 
XCH were characterized by studying the changes in pH of the core of XCH on 
external pH variation such as gastric acidity.  The barrier properties were found to 
depend on the factors affecting the hydrogel structure such as molecular weight of 
chitosan, complexation time, and xanthan concentration.  Formation of a dense 
hydrogel membrane was found to be critical in retarding gastric fluid diffusion.   
 Viability studies revealed that despite strong antimicrobial behavior of 
chitosan when acting alone, no antimicrobial effect on probiotic L. acidophilus was 
observed when combined with xanthan.  A thicker hydrogel outer layer formed by 
HMW chitosan resulted in best protective effects on the viability of L. acidophilus 
against SGJ compared to porous hydrogel formed by LMW chitosan, indicating the 
importance of molecular weight dependent membrane structure.  The protective 
effects of probiotics against SGJ were further improved with the formation of XCXH 
hydrogels compared to XCH due to the formation of a thicker hydrogel layer, 
resulting in enhanced stability in SGJ.  Reduced XCXH capsule size had adverse 
effect on the protective effects, though still significantly higher than free cells in SGJ.   
 Moreover, application of XCXH capsules in stirred yogurt resulted in higher 
viability during refrigerated storage conditions and retained the bile resistance of L. 
acidophilus ATCC 43121.  This indicates that, with XCXH encapsulation, it is 
possible to achieve the delivery of a therapeutic minimum number of probiotic 




future studies focus on evaluation of XCXH capsules in other food systems such as 
non-fermented dairy beverages and dry food products. Developing the technology 
required in manufacturing small and uniformly sized capsules will be crucial in 
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